Valbiotis SAS (ALVAL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.592x

Based on the latest financial reports, Valbiotis SAS (ALVAL) has a cash flow conversion efficiency ratio of -0.592x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.12 Million ≈ $-4.82 Million USD) by net assets (€6.96 Million ≈ $8.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALVAL market cap for the company's overall valuation and market capitalisation.

Valbiotis SAS - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Valbiotis SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Valbiotis SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Valbiotis SAS ranked by their cash flow conversion efficiency. See ALVAL operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
SPARK VC S.A. ZY 10 F:8N2	-0.015x
Sun Race Sturmey-Archer Inc TW:1526	0.044x
UMediC Group Berhad KLSE:0256	-0.034x
DIAMINES AND CHEMICALS ORD (BSE) NSE:DIAMINESQ	-0.045x
Hankukpackage Co. Ltd KQ:037230	0.048x
Izostal SA WAR:IZS	-0.217x
Coastal Corporation Limited NSE:COASTCORP	0.093x
Farmer Bros. Co NASDAQ:FARM	-0.125x

Annual Cash Flow Conversion Efficiency for Valbiotis SAS (2015–2025)

The table below shows the annual cash flow conversion efficiency of Valbiotis SAS from 2015 to 2025. View Valbiotis SAS share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€6.96 Million ≈ $8.14 Million	€-8.04 Million ≈ $-9.40 Million	-1.155x	-3.77%
2024-12-31	€10.37 Million ≈ $12.12 Million	€-11.54 Million ≈ $-13.49 Million	-1.113x	-170.73%
2023-12-31	€19.60 Million ≈ $22.91 Million	€-8.06 Million ≈ $-9.42 Million	-0.411x	+40.47%
2022-12-31	€13.31 Million ≈ $15.56 Million	€-9.19 Million ≈ $-10.75 Million	-0.690x	-37.31%
2021-12-31	€14.23 Million ≈ $16.64 Million	€-7.16 Million ≈ $-8.37 Million	-0.503x	-232.07%
2020-12-31	€7.07 Million ≈ $8.27 Million	€2.69 Million ≈ $3.15 Million	0.381x	+163.19%
2019-12-31	€8.21 Million ≈ $9.60 Million	€-4.95 Million ≈ $-5.78 Million	-0.603x	+1.80%
2018-12-31	€7.41 Million ≈ $8.66 Million	€-4.55 Million ≈ $-5.31 Million	-0.614x	-186.99%
2017-12-31	€10.16 Million ≈ $11.88 Million	€-2.17 Million ≈ $-2.54 Million	-0.214x	+90.81%
2016-12-31	€369.00K ≈ $431.40K	€-858.00K ≈ $-1.00 Million	-2.325x	+73.80%
2015-12-31	€80.00K ≈ $93.53K	€-710.00K ≈ $-830.06K	-8.875x	--

About Valbiotis SAS

PA:ALVAL France Packaged Foods

Market Cap

$30.21 Million

€25.84 Million EUR

Market Cap Rank

#24138 Global

#385 in France

Share Price

€0.73

Change (1 day)

-2.93%

52-Week Range

€0.55 - €1.21

All Time High

€10.54